Blackstone Inc E Ffector Therapeutics, Inc. Transaction History

Blackstone Inc

  • $21.3 Billion
  • Q3 2024

A detailed history of Blackstone Inc transactions in E Ffector Therapeutics, Inc. stock. As of the latest transaction made, Blackstone Inc holds 52,343 shares of EFTR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,343
Previous 52,343 -0.0%
Holding current value
$0
Previous $15,000 86.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.42 - $16.95 $527,622 - $21.3 Million
-1,256,244 Reduced 96.0%
52,343 $753,000
Q3 2021

Nov 16, 2021
BUY
$8.56 - $27.17 $11.2 Million - $35.6 Million
1,308,587 New
1,308,587 $18.4 Million

Others Institutions Holding EFTR

# of Institutions
5
Shares Held
6.46M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email